Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer

BackgroundAlternative splicing (AS) is reported to be related to the biological process of multiple malignancies. This study is conducted to identify survival-associated AS events and prognostic signatures that may serve as prognostic indicators for pancreatic cancer (PC).MethodsUnivariate Cox analy...

Full description

Bibliographic Details
Main Authors: Lichao Xu, Jingxin Pan, Yanni Ding, Hongda Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.522383/full
_version_ 1818144614380470272
author Lichao Xu
Lichao Xu
Jingxin Pan
Yanni Ding
Hongda Pan
author_facet Lichao Xu
Lichao Xu
Jingxin Pan
Yanni Ding
Hongda Pan
author_sort Lichao Xu
collection DOAJ
description BackgroundAlternative splicing (AS) is reported to be related to the biological process of multiple malignancies. This study is conducted to identify survival-associated AS events and prognostic signatures that may serve as prognostic indicators for pancreatic cancer (PC).MethodsUnivariate Cox analysis was used to determine the survival-associated AS events in PC. Prognostic signatures were constructed by LASSO Cox analysis based on seven types of survival-associated AS events. The correlation between the expression of splicing factors (SFs) and the percent spliced in values of AS events was analyzed by Pearson correlation analysis. Risk scores were calculated to determine high- or low-risk patients with different types of AS events. Gene functional annotation analysis was performed to reveal pathways in which prognostic AS is enriched.ResultsA total of 45,313 AS events in 10,624 genes were observed, and there were 1,565 AS events in 1,223 genes significantly correlated with overall survival for PC. Kaplan–Meier analysis, receiver-operator characteristic curve, univariate and multivariate Cox analyses showed that AS prognostic signatures could effectively predict prognosis of patients with PC. Splicing factors–AS regulatory networks were established to demonstrate the interaction between AS events and SFs.ConclusionThe survival-associated AS events and prognostic signatures identified in this study can serve as useful tool for predicting prognosis of patients with PC. Moreover, the SF–AS regulatory networks may provide clues for the mechanisms underlying AS in PC.
first_indexed 2024-12-11T11:50:22Z
format Article
id doaj.art-ea8746009aa54ffc97a58368fa98653f
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-11T11:50:22Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-ea8746009aa54ffc97a58368fa98653f2022-12-22T01:08:22ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-09-011110.3389/fgene.2020.522383522383Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic CancerLichao Xu0Lichao Xu1Jingxin Pan2Yanni Ding3Hongda Pan4Department of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Internal Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, ChinaDepartment of Surgery, Shaan Xi Provincial Tumor Hospital, Xi’an City, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaBackgroundAlternative splicing (AS) is reported to be related to the biological process of multiple malignancies. This study is conducted to identify survival-associated AS events and prognostic signatures that may serve as prognostic indicators for pancreatic cancer (PC).MethodsUnivariate Cox analysis was used to determine the survival-associated AS events in PC. Prognostic signatures were constructed by LASSO Cox analysis based on seven types of survival-associated AS events. The correlation between the expression of splicing factors (SFs) and the percent spliced in values of AS events was analyzed by Pearson correlation analysis. Risk scores were calculated to determine high- or low-risk patients with different types of AS events. Gene functional annotation analysis was performed to reveal pathways in which prognostic AS is enriched.ResultsA total of 45,313 AS events in 10,624 genes were observed, and there were 1,565 AS events in 1,223 genes significantly correlated with overall survival for PC. Kaplan–Meier analysis, receiver-operator characteristic curve, univariate and multivariate Cox analyses showed that AS prognostic signatures could effectively predict prognosis of patients with PC. Splicing factors–AS regulatory networks were established to demonstrate the interaction between AS events and SFs.ConclusionThe survival-associated AS events and prognostic signatures identified in this study can serve as useful tool for predicting prognosis of patients with PC. Moreover, the SF–AS regulatory networks may provide clues for the mechanisms underlying AS in PC.https://www.frontiersin.org/article/10.3389/fgene.2020.522383/fullpancreatic canceralternative splicingsplicing factorsprognosisThe Cancer Genome Atlas
spellingShingle Lichao Xu
Lichao Xu
Jingxin Pan
Yanni Ding
Hongda Pan
Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
Frontiers in Genetics
pancreatic cancer
alternative splicing
splicing factors
prognosis
The Cancer Genome Atlas
title Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
title_full Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
title_fullStr Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
title_full_unstemmed Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
title_short Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
title_sort survival associated alternative splicing events and prognostic signatures in pancreatic cancer
topic pancreatic cancer
alternative splicing
splicing factors
prognosis
The Cancer Genome Atlas
url https://www.frontiersin.org/article/10.3389/fgene.2020.522383/full
work_keys_str_mv AT lichaoxu survivalassociatedalternativesplicingeventsandprognosticsignaturesinpancreaticcancer
AT lichaoxu survivalassociatedalternativesplicingeventsandprognosticsignaturesinpancreaticcancer
AT jingxinpan survivalassociatedalternativesplicingeventsandprognosticsignaturesinpancreaticcancer
AT yanniding survivalassociatedalternativesplicingeventsandprognosticsignaturesinpancreaticcancer
AT hongdapan survivalassociatedalternativesplicingeventsandprognosticsignaturesinpancreaticcancer